Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
65
INBX Quote, Financials, Valuation and Earnings
Last price:
$86.43
Seasonality move
:
-1.71%
Day range:
$84.39 - $91.20
52-week range:
$10.81 - $94.47
Dividend yield:
0%
P/E ratio:
0.20x
P/S ratio:
936.51x
P/B ratio:
33.85x
Volume:
564.5K
Avg. volume:
274K
1-year change:
520.53%
Market cap:
$1.2B
Revenue:
$200K
EPS (TTM):
-$10.24
Earnings Data
Next earnings date for INBX
Mar 31
2026
Most recent earnings per share
-$2.28
Missed by $0.56
(Nov 14/2025)
Consensus Estimate
-$1.72
(Nov 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
INBX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q4 | -- | -- | -- | -$2.08 | -- |
| 11/14/2025 | Q3 | -- | -- | -$2.28 | -$1.72 | -$0.56 |
| 08/13/2025 | Q2 | -- | $1.3M | -$1.85 | -$2.60 | $0.75 |
| 05/14/2025 | Q1 | -- | -- | -$2.80 | -$3.12 | $0.32 |
| 03/17/2025 | Q4 | -- | $100K | -$3.31 | -$2.89 | -$0.42 |
| 11/14/2024 | Q3 | -- | -- | -$3.03 | -$3.70 | $0.67 |
| 08/13/2024 | Q2 | -- | $100K | $128.35 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$5.44 | -- | -- |
| 12/31/2023 | Q4 | -- | $1.6M | -$6.57 | -- | -- |
| 09/30/2023 | Q3 | -- | $119K | -$3.64 | -- | -- |
| 06/30/2023 | Q2 | -- | $30K | -$3.25 | -- | -- |
| 03/31/2023 | Q1 | -- | $17K | -$3.38 | -- | -- |
Inhibrx Biosciences, Inc. Earnings Questions
-
How Much did Inhibrx Biosciences, Inc. Generate in Revenue Last Quarter?
Inhibrx Biosciences, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Inhibrx Biosciences, Inc. Beat Earnings Last Quarter?
Inhibrx Biosciences, Inc. announced earnings per share of -$2.28 which represents a miss of analyst forecast a -$1.72 per share.
-
Is Inhibrx Biosciences, Inc. Profitable?
Inhibrx Biosciences, Inc. reported -$582K that represents -$0.04 per share over the last quarter.
-
What is the Analyst Consensus for Inhibrx Biosciences, Inc. EPS Next Year?
Inhibrx Biosciences, Inc.'s earnings are forecast to decrease from $116.58 per share to -$9.01 per share next year representing a decrease of -25.66%.
-
When is Inhibrx Biosciences, Inc.'s Earnings Date?
Inhibrx Biosciences, Inc.'s next earnings date is March 31, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
